查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820638

全球口腔黏膜药物市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

Global Oral Transmucosal Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格

预计 2025 年至 2033 年间，全球口腔黏膜药物市场将以 6.98% 的显着复合年增长率成长。到 2033 年，市场规模预计将飙升至 754.8 亿美元，较 2024 年的 411.2 亿美元大幅成长。

全球口腔黏膜药物市场可望在非侵入性、速效给药系统需求不断增长的推动下实现成长。口腔黏膜给药途径（包括颊黏膜和舌下黏膜）具有绕过首过代谢和提高患者依从性等优势。未来的发展将着重于新型製剂、黏膜黏附技术和奈米载体系统，以提高生物利用度和疗效。

此外，慢性疼痛、神经系统疾病和心血管疾病的盛行率不断上升，其应用领域也不断扩展。药物输送设备和个人化医疗的进步进一步推动了市场成长。支持创新输送系统的监管框架正在促进其商业化。随着以患者为中心的疗法日益受到重视，口腔黏膜药物市场将持续创新，提供有效、便利、安全的治疗方案。

目录

第一章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：口腔黏膜药物 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按产品类型
    • 按给药途径进行的市场吸引力分析
    • 按适应症分析市场吸引力
    • 按配销通路分析市场吸引力
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第五章：全球口腔黏膜药物市场分析：依产品类型

  • 概览：依产品类型
  • 历史与预测资料分析：按产品类型
  • 平板电脑
  • 电影
  • 液体和喷雾
  • 其他产品类型

第六章：全球口腔黏膜药物市场分析：依给药途径

  • 依给药途径概述
  • 按给药途径进行的历史和预测数据分析
  • 舌下黏膜
  • 颊粘膜
  • 其他给药途径

第七章：全球口腔黏膜药物市场分析：按适应症

  • 按适应症概述
  • 依适应症分析历史和预测数据
  • 阿片类药物依赖
  • 噁心和呕吐
  • 性功能障碍
  • 神经系统疾病
  • 其他适应症

第 8 章：全球口腔黏膜药物市场分析：按分销管道

  • 按配销通路概览
  • 按配销通路进行历史和预测资料分析
  • 医院药房
  • 零售药局
  • 网路药局

第九章：全球口腔黏膜药物市场分析：按地区

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 10 章：口腔黏膜药物公司的竞争格局

  • 口腔黏膜药物市场竞争
  • 伙伴关係/合作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Aquestive Therapeutics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • CLPharm Co. Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cure Pharmaceutical
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • IntelGenx Technologies Corp
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Jazz Pharmaceuticals Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • NAL Pharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Teva Pharmaceutical Industries Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ZIM Laboratories Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

Product Code: VMR112114088

The global Oral Transmucosal Drugs market is forecasted to grow at a noteworthy CAGR of 6.98% between 2025 and 2033. By 2033, market size is expected to surge to USD 75.48 Billion, a substantial rise from the USD 41.12 Billion recorded in 2024.

The global oral transmucosal drugs market is poised for growth driven by increasing demand for non-invasive, rapid-onset drug delivery systems. Oral transmucosal routes, including buccal and sublingual, offer advantages such as bypassing first-pass metabolism and improving patient compliance. Future developments will focus on novel formulations, mucoadhesive technologies, and nanocarrier systems to enhance bioavailability and therapeutic efficacy.

Moreover, rising prevalence of chronic pain, neurological disorders, and cardiovascular diseases is expanding application areas. Advances in drug delivery devices and personalized medicine are further propelling market growth. Regulatory frameworks supporting innovative delivery systems are facilitating commercialization. As patient-centric therapies gain prominence, the oral transmucosal drugs market will continue to innovate, delivering effective, convenient, and safe treatment options.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Oral Transmucosal Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Tablets
  • Films
  • Liquid & Spray
  • Other Product Types

By Route Of Administration

  • Sublingual Mucosa
  • Buccal Mucosa
  • Other Routes Of Administration

By Indication

  • Opioid Dependence
  • Nausea And Vomiting
  • Erectile Dysfunction
  • Neurological Disorders
  • Other Indications

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • List of Companies Profiled in the report
  • Aquestive Therapeutics Inc., C.L.Pharm Co. Ltd., Cure Pharmaceutical, IntelGenx Technologies Corp, Jazz Pharmaceuticals plc, NAL Pharma, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Limited, ZIM Laboratories Limited.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ORAL TRANSMUCOSAL DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Route Of Administration
    • 3.7.3 Market Attractiveness Analysis By Indication
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Tablets Historic and Forecast Sales By Regions
  • 5.4. Films Historic and Forecast Sales By Regions
  • 5.5. Liquid & Spray Historic and Forecast Sales By Regions
  • 5.6. Other Product Types Historic and Forecast Sales By Regions

6. GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route Of Administration
  • 6.2. Historical and Forecast Data Analysis By Route Of Administration
  • 6.3. Sublingual Mucosa Historic and Forecast Sales By Regions
  • 6.4. Buccal Mucosa Historic and Forecast Sales By Regions
  • 6.5. Other Routes Of Administration Historic and Forecast Sales By Regions

7. GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET ANALYSIS BY INDICATION

  • 7.1. Overview By Indication
  • 7.2. Historical and Forecast Data Analysis By Indication
  • 7.3. Opioid Dependence Historic and Forecast Sales By Regions
  • 7.4. Nausea And Vomiting Historic and Forecast Sales By Regions
  • 7.5. Erectile Dysfunction Historic and Forecast Sales By Regions
  • 7.6. Neurological Disorders Historic and Forecast Sales By Regions
  • 7.7. Other Indications Historic and Forecast Sales By Regions

8. GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ORAL TRANSMUCOSAL DRUGS COMPANIES

  • 10.1. Oral Transmucosal Drugs Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ORAL TRANSMUCOSAL DRUGS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Aquestive Therapeutics Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. C.L.Pharm Co. Ltd.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Cure Pharmaceutical
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. IntelGenx Technologies Corp
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Jazz Pharmaceuticals Plc
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. NAL Pharma
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Novartis AG
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Pfizer Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Teva Pharmaceutical Industries Limited
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. ZIM Laboratories Limited
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Films Market Sales By Geography (USD MN)
  • Liquid & Spray Market Sales By Geography (USD MN)
  • Other Product Types Market Sales By Geography (USD MN)
  • Analysis By Route Of Administration (USD MN)
  • Sublingual Mucosa Market Sales By Geography (USD MN)
  • Buccal Mucosa Market Sales By Geography (USD MN)
  • Other Routes Of Administration Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Opioid Dependence Market Sales By Geography (USD MN)
  • Nausea And Vomiting Market Sales By Geography (USD MN)
  • Erectile Dysfunction Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Other Indications Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Oral Transmucosal Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Oral Transmucosal Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Oral Transmucosal Drugs Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Route Of Administration
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Films Market Sales By Geography (USD MN)
  • Liquid & Spray Market Sales By Geography (USD MN)
  • Other Product Types Market Sales By Geography (USD MN)
  • Global Market Analysis By Route Of Administration (USD MN)
  • Sublingual Mucosa Market Sales By Geography (USD MN)
  • Buccal Mucosa Market Sales By Geography (USD MN)
  • Other Routes Of Administration Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Opioid Dependence Market Sales By Geography (USD MN)
  • Nausea And Vomiting Market Sales By Geography (USD MN)
  • Erectile Dysfunction Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Other Indications Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.